Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Crystal structure of Clostridium botulinum whole hemagglutinin reveals a huge triskelion-shaped molecular complex.

Amatsu S, Sugawara Y, Matsumura T, Kitadokoro K, Fujinaga Y.

J Biol Chem. 2013 Dec 6;288(49):35617-25. doi: 10.1074/jbc.M113.521179. Epub 2013 Oct 28.

2.

Functional dissection of the Clostridium botulinum type B hemagglutinin complex: identification of the carbohydrate and E-cadherin binding sites.

Sugawara Y, Yutani M, Amatsu S, Matsumura T, Fujinaga Y.

PLoS One. 2014 Oct 23;9(10):e111170. doi: 10.1371/journal.pone.0111170. eCollection 2014.

3.

Molecular properties of each subcomponent in Clostridium botulinum type B haemagglutinin complex.

Arimitsu H, Sakaguchi Y, Lee JC, Ochi S, Tsukamoto K, Yamamoto Y, Ma S, Tsuji T, Oguma K.

Microb Pathog. 2008 Aug;45(2):142-9. doi: 10.1016/j.micpath.2008.04.007. Epub 2008 May 8.

PMID:
18550324
4.

Molecular characterization of binding subcomponents of Clostridium botulinum type C progenitor toxin for intestinal epithelial cells and erythrocytes.

Fujinaga Y, Inoue K, Watarai S, Sakaguchi Y, Arimitsu H, Lee JC, Jin Y, Matsumura T, Kabumoto Y, Watanabe T, Ohyama T, Nishikawa A, Oguma K.

Microbiology. 2004 May;150(Pt 5):1529-38.

PMID:
15133114
5.

Structural analysis by X-ray crystallography and calorimetry of a haemagglutinin component (HA1) of the progenitor toxin from Clostridium botulinum.

Inoue K, Sobhany M, Transue TR, Oguma K, Pedersen LC, Negishi M.

Microbiology. 2003 Dec;149(Pt 12):3361-70.

PMID:
14663070
6.

Molecular basis for disruption of E-cadherin adhesion by botulinum neurotoxin A complex.

Lee K, Zhong X, Gu S, Kruel AM, Dorner MB, Perry K, Rummel A, Dong M, Jin R.

Science. 2014 Jun 20;344(6190):1405-10. doi: 10.1126/science.1253823.

7.

Crystal structure of the HA3 subcomponent of Clostridium botulinum type C progenitor toxin.

Nakamura T, Kotani M, Tonozuka T, Ide A, Oguma K, Nishikawa A.

J Mol Biol. 2009 Jan 30;385(4):1193-206. doi: 10.1016/j.jmb.2008.11.039. Epub 2008 Nov 27.

PMID:
19071137
8.

A novel subunit structure of Clostridium botulinum serotype D toxin complex with three extended arms.

Hasegawa K, Watanabe T, Suzuki T, Yamano A, Oikawa T, Sato Y, Kouguchi H, Yoneyama T, Niwa K, Ikeda T, Ohyama T.

J Biol Chem. 2007 Aug 24;282(34):24777-83. Epub 2007 Jun 20.

9.

Conformational divergence in the HA-33/HA-17 trimer of serotype C and D botulinum toxin complex.

Sagane Y, Hayashi S, Akiyama T, Matsumoto T, Hasegawa K, Yamano A, Suzuki T, Niwa K, Watanabe T, Yajima S.

Biochem Biophys Res Commun. 2016 Aug 5;476(4):280-285. doi: 10.1016/j.bbrc.2016.05.113. Epub 2016 May 27.

PMID:
27237978
10.

Characterization and reconstitution of functional hemagglutinin of the Clostridium botulinum type C progenitor toxin.

Kouguchi H, Watanabe T, Sagane Y, Ohyama T.

Eur J Biochem. 2001 Jul;268(14):4019-26.

11.

Crystallization and preliminary X-ray analysis of a novel haemagglutinin component of the toxin complex of serotype C Clostridium botulinum.

Hayashi S, Akiyama T, Sagane Y, Miyashita S, Watanabe T, Yajima S, Niwa K.

Acta Crystallogr F Struct Biol Commun. 2014 Mar;70(Pt 3):370-3. doi: 10.1107/S2053230X14003094. Epub 2014 Feb 20.

12.

Sugar-induced conformational change found in the HA-33/HA-17 trimer of the botulinum toxin complex.

Sagane Y, Hayashi S, Matsumoto T, Miyashita S, Inui K, Miyata K, Yajima S, Suzuki T, Hasegawa K, Yamano A, Nishikawa A, Ohyama T, Watanabe T, Niwa K.

Biochem Biophys Res Commun. 2013 Aug 30;438(3):483-7. doi: 10.1016/j.bbrc.2013.07.112. Epub 2013 Aug 2.

PMID:
23916708
13.

Hemagglutinin gene shuffling among Clostridium botulinum serotypes C and D yields distinct sugar recognition of the botulinum toxin complex.

Miyata K, Suzuki T, Hayashi S, Miyashita S, Ohyama T, Niwa K, Watanabe T, Sagane Y.

Pathog Dis. 2015 Oct;73(7). pii: ftv054. doi: 10.1093/femspd/ftv054. Epub 2015 Jul 29.

PMID:
26223883
14.

Structure of a bimodular botulinum neurotoxin complex provides insights into its oral toxicity.

Lee K, Gu S, Jin L, Le TT, Cheng LW, Strotmeier J, Kruel AM, Yao G, Perry K, Rummel A, Jin R.

PLoS Pathog. 2013;9(10):e1003690. doi: 10.1371/journal.ppat.1003690. Epub 2013 Oct 10.

15.

Carbohydrate recognition mechanism of HA70 from Clostridium botulinum deduced from X-ray structures in complexes with sialylated oligosaccharides.

Yamashita S, Yoshida H, Uchiyama N, Nakakita Y, Nakakita S, Tonozuka T, Oguma K, Nishikawa A, Kamitori S.

FEBS Lett. 2012 Jul 30;586(16):2404-10. doi: 10.1016/j.febslet.2012.05.055. Epub 2012 Jun 7.

16.

Identification and characterization of functional subunits of Clostridium botulinum type A progenitor toxin involved in binding to intestinal microvilli and erythrocytes.

Fujinaga Y, Inoue K, Nomura T, Sasaki J, Marvaud JC, Popoff MR, Kozaki S, Oguma K.

FEBS Lett. 2000 Feb 11;467(2-3):179-83.

17.

Molecular composition of Clostridium botulinum type A progenitor toxins.

Inoue K, Fujinaga Y, Watanabe T, Ohyama T, Takeshi K, Moriishi K, Nakajima H, Inoue K, Oguma K.

Infect Immun. 1996 May;64(5):1589-94.

18.

Clostridium botulinum type C hemagglutinin affects the morphology and viability of cultured mammalian cells via binding to the ganglioside GM3.

Sugawara Y, Iwamori M, Matsumura T, Yutani M, Amatsu S, Fujinaga Y.

FEBS J. 2015 Sep;282(17):3334-47. doi: 10.1111/febs.13346. Epub 2015 Jul 14.

19.

Role of C-terminal region of HA-33 component of botulinum toxin in hemagglutination.

Sagane Y, Kouguchi H, Watanabe T, Sunagawa H, Inoue K, Fujinaga Y, Oguma K, Ohyama T.

Biochem Biophys Res Commun. 2001 Nov 2;288(3):650-7.

PMID:
11676492
20.

Molecular construction of Clostridium botulinum type C progenitor toxin and its gene organization.

Fujinaga Y, Inoue K, Shimazaki S, Tomochika K, Tsuzuki K, Fujii N, Watanabe T, Ohyama T, Takeshi K, Inoue K, et al.

Biochem Biophys Res Commun. 1994 Dec 15;205(2):1291-8.

PMID:
7802661

Supplemental Content

Support Center